FAH rebuts Senate hearing claims, clarifying taxpaying hospitals do not benefit from the 340B drug pricing program discounts.

The American Society of Health-System Pharmacists is urging lawmakers to protect the 340B Drug Pricing Program, warning that changes to the discount model could destabilize safety-net hospitals. In an ...

AHA writes to express our strong support for this vital program that allows eligible hospitals to maintain, improve and expand access to essential services and medications for the patients and ...

The Senate Committee on Health, Education, Labor and Pensions Oct. 23 held a hearing ( discussing the 340B program and its growth and impacts on patients.

A discount drug program is being abused by large hospital chains in Chicago leaving communities on the South and West sides ...

A bipartisan group of senators is working to draft legislation to reform a fast-growing hospital drug discount program designed to help low-income patients.

But when it comes to the federal 340B Drug Pricing Program, recent legislative efforts to expand it — through House Bill 276 ...

A network of over 30 rural and urban nonprofit safety net providers appealed to congressional leaders to protect the 340B Drug Pricing Program, highlighting how the program enables the high-quality ...

The 340B Drug Pricing Program (the Program) has long been a cornerstone for healthcare providers seeking to deliver affordable care to underserved communities. However, as the regulatory and ...

The Health Resources and Services Administration has sent a letter to Johnson & Johnson warning the company of the consequences if it proceeds with its planned 340B rebate proposal. In a Sept. 17 ...

The 340B Drug Pricing Program is a federal lifeline for vulnerable and underserved communities across the U.S., and its importance in Orlando is profound. Created to allow health-care safety-net ...